The government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 2030. Focus remains on quality, affordability, and continuity in global healthcare supply chains.

India is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug exports. The Indian pharma market is set…

India is willing to open its pharma market to innovative products while seeking better access for drug exports, says Commerce Minister Piyush Goyal.

India's pharma exports are set to reach $50 billion by 2030, driven by affordability and global market diversification.